Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Patient plan: look up a medication list

BISACODYL

All products: general benefit

Other products in the same Health Canada class (A06A, A06AB) — coverage varies; not interchangeable

  • Citric acid + oxide + picosulfate (Pico-Salax): general benefit
  • Docusate dioctyl sulfosuccinate (Docusate Sodium): general benefit
  • Citrus fibre + grain (Novo-Fibre): general benefit, Not a benefit
  • Lactulose (PMS-Lactulose): general benefit
  • Mineral oil (Fleet Enema Mineral Oil): general benefit

Dulcolax · DIN 00003875 · 10mg · suppository

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Dulcolax · DIN 00003875 Manufacturer: Sanofi Consumer Health Inc.; listing date 1996-10-01 Health Canada: Marketed since 2026-08-24 · brand DULCOLAX · ATC A06AB02 BISACODYL · form Suppository · route Rectal · ingredients BISACODYL 10 MG · company Opella canada inc. · schedule Non-prescription drugs
Check this DIN again · Health Canada product record

Ministry pays: $0.4206 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=1555 · Verify on the e-Formulary ↗ (DIN 00003875)

Source record
DIN 00003875: Dulcolax Raw flags: sec3=Y, selfMed=Y Item: 561200002; group id 648; item number 1628; lccId None; manufacturer id SCO Source form: Sup; strength: 10mg Recorded listing: General benefit; self-medication (OTC-type) product Source prices (unrounded): $1.2267; ministry $0.4206 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=00003875 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=1555
Interchangeable products
AMB-Bisacodyl · DIN 02520478 · $0.4206 Bisacodyl 10mg · DIN 02458853 · $0.4206 Bisacodyl Suppository · DIN 02361450 · $0.4206
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00003875
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Other drugs in the same formulary class (56:12 Cathartics) and how they are covered

Matched class: 56:12 Cathartics

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Covered without a code on the Ontario formulary: DOCUSATE SODIUM (DIOCTYL SODIUM SULFOSUCCINATE), LACTULOSE, MAGNESIUM OXIDE & CITRIC ACID & SODIUM PICOSULFATE, MINERAL OIL, PSYLLIUM MUCILLOID, SENNOSIDES A & B, SODIUM BIPHOSPHATE & SODIUM PHOSPHATE Some products covered without a code (check the product listing): GRAIN & CITRUS FIBRE 56:12 Cathartics

MAGNESIUM OXIDE & CITRIC ACID & SODIUM PICOSULFATE

· 2 products · General benefit · strengths: 3.5g & 12g & 10mg · Pd for Sol-12g Sachet

DOCUSATE SODIUM (DIOCTYL SODIUM SULFOSUCCINATE)

· 6 products · General benefit · strengths: 100mg, 4mg/mL, 10mg/mL · Cap, O/L

GRAIN & CITRUS FIBRE

· 2 products · General benefit (1), Listed, not a benefit (1) · strengths: · Tab

LACTULOSE

· 1 products · General benefit · strengths: 667mg/mL · O/L

MINERAL OIL

· 1 products · General benefit · strengths: 100% · Enema

PSYLLIUM MUCILLOID

· 1 products · General benefit · strengths: · Oral Pd

SENNOSIDES A & B

· 2 products · General benefit · strengths: 8.6mg · Tab

SODIUM BIPHOSPHATE & SODIUM PHOSPHATE

· 2 products · General benefit · strengths: 160mg & 60mg/mL · Ped Rect Sol, Rect Sol (with Preservative) Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26; class 56:12
Full class listing Related classes: 56:04 Antacids and Adsorbents, 56:08 Antidiarrhea Agents, 56:16 Digestants, 56:22 Antiemetics and Antinauseants, 56:40 Miscellaneous G.I. Drugs Same formulary class, not same indication: class membership alone does not establish equivalent uses.
Other drugs whose Health Canada label lists a similar indication: constipation
From Health Canada product monographs; label wording only, not a treatment recommendation. Matching is lexical and uses one held product label per generic; formulations and qualifying criteria may differ. No displayed matched alternative is a general benefit. PEG-ELECTROLYTES · Listed, not a benefit (1), General benefit (2) INDICATIONS AND CLINICAL USE Adults Colyte® (PEG 3350 and Electrolytes) is indicated for:  bowel cleansing prior to colonoscopy or barium enema x-ray examination or surgical procedures requiring a clean colon.  the treatment of constipation PM: https://pdf.hres.ca/dpd_pm/00061814.PDF; date March 25, 2021; DIN 00677442; fetched 2026-09-10 Product monograph PRUCALOPRIDE · Off-Formulary Interchangeable, not an ODB benefit 1 INDICATIONS RESOTRAN® (prucalopride succinate tablets) is indicated for: • The treatment of chronic idiopathic constipation in adult female patients in whom laxatives failed to provide adequate relief. PM: https://pdf.hres.ca/dpd_pm/00073288.PDF; date NOV 08, 2023; DIN 02377012; fetched 2026-09-10 Product monograph Coverage source: ON formulary extract 2026-08-26
What the Health Canada label says it is for
INDICATIONS AND CLINICAL USE DULCOLAX is indicated for: • Relief of occasional constipation • Under medical supervision, for the preparation of diagnostic procedures, in pre- and postoperative treatment, and in conditions which require defecation to be facilitated. https://pdf.hres.ca/dpd_pm/00076868.PDF PM date: November 3, 2022 Source product: DULCOLAX; DIN 00003875; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.